Reactive stroma initiates during early prostate cancer development and coevolves with prostate cancer progression.
Previous studies have defined the key markers of reactive stroma and have established that reactive stroma biology influences prostate tumorigenesis and progression. The stem/progenitor cells of origin and the mechanisms that regulate their recruitment and activation to myofibroblasts or carcinoma-associated fibroblasts are essentially unknown. Key regulatory factors have been identified, including transforming growth factor β, interleukin-8, fibroblast growth factors, connective tissue growth factor, wingless homologs-Wnts, and stromal cell-derived factor-1, among others. The biology of reactive stroma in cancer is similar to the more predictable biology of the stroma compartment during wound repair at sites where the epithelial barrier function is breached and a stromal response is generated. The coevolution of reactive stroma and the biology of how reactive stroma-carcinoma interactions regulate cancer progression and metastasis are targets for new therapeutic approaches. Such approaches are strategically designed to inhibit cancer progression by uncoupling the reactive stroma niche.
Written by:
Barron DA, Rowley DR. Are you the author?
Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, 325D, mailstop BCM130, Houston, Texas 77030, USA.
Reference: Endocr Relat Cancer. 2012 Oct 30;19(6):R187-204.
doi: 10.1530/ERC-12-0085
PubMed Abstract
PMID: 22930558
UroToday.com Investigative Urology Section
